REQUEST A DEMO
Total
USD $0.00
Search more companies

Bio-Caps India Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bio-Caps India Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Bio-Caps India Limited is a company in India, with a head office in Hooghly. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on March 06, 2003. Bio-Caps India Limited currently employs 85 (2025) people. The latest financial highlights indicate a net sales revenue increase of 5.09% in 2025. Its’ total assets recorded a growth of 3.42%. In, 2025, the company’s net profit margin increased by 0.04%.

Legal Address
Dankuni Expressway, Post - Dankuni Cole Complex
Hooghly; West Bengal; Postal Code: 712310

Contact Details: Purchase the Bio-Caps India Limited report to view the information.

Basic Information
Total Employees:
Purchase the Bio-Caps India Limited report to view the information.
Registered Capital:
Purchase the Bio-Caps India Limited report to view the information.
Financial Auditors:
Purchase the Bio-Caps India Limited report to view the information.
Incorporation Date:
March 06, 2003
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Additional Executive Director
Ownership Details
Purchase this report to view the information.
0.38%
Company Performance
Financial values in the chart are available after Bio-Caps India Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
5.09%
Total Operating Revenue
3.89%
Operating Profit
18.6%
EBITDA
0.99%
Net Profit/Loss for the Period
6.02%
Total Assets
3.42%
Total Equity
-2.02%
Operating Profit Margin
0.63%
Net Profit Margin
0.04%
Return on Equity (ROE)
0.08%
Debt / Equity
34.67%
Quick Ratio
-0.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?